close 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Investeringen brengen risico`s met zich mee en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 74% van de retail beleggers lijdt verlies op de handel in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

MDT

86.56

+0.83%ā†‘

A

113.95

+1.74%ā†‘

VEEV

175.31

+0.07%ā†‘

HQY

83.18

+1.87%ā†‘

CSBR

5.69

+2.34%ā†‘

MDT

86.56

+0.83%ā†‘

A

113.95

+1.74%ā†‘

VEEV

175.31

+0.07%ā†‘

HQY

83.18

+1.87%ā†‘

CSBR

5.69

+2.34%ā†‘

MDT

86.56

+0.83%ā†‘

A

113.95

+1.74%ā†‘

VEEV

175.31

+0.07%ā†‘

HQY

83.18

+1.87%ā†‘

CSBR

5.69

+2.34%ā†‘

MDT

86.56

+0.83%ā†‘

A

113.95

+1.74%ā†‘

VEEV

175.31

+0.07%ā†‘

HQY

83.18

+1.87%ā†‘

CSBR

5.69

+2.34%ā†‘

MDT

86.56

+0.83%ā†‘

A

113.95

+1.74%ā†‘

VEEV

175.31

+0.07%ā†‘

HQY

83.18

+1.87%ā†‘

CSBR

5.69

+2.34%ā†‘

Home惻Aandelen Lijst惻Cellectar Biosciences Inc
Search

Cellectar Biosciences Inc

Gesloten

2.45 -5.41

Buy

Prijsupdate 31 mrt 2026, 19:59 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.4

Max

2.7800000000000002

Belangrijke statistieken

By Trading Economics

Werknemers

11

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+344.44% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

15M

Vorige openingsprijs

7.86

Vorige sluitingsprijs

2.45

Cellectar Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

30 mrt 2026, 23:15 UTC

Belangrijke Nieuwsgebeurtenissen

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

DJ

Lezen

30 mrt 2026, 22:36 UTC

Belangrijke Nieuwsgebeurtenissen

Australian Government Rules Out Boots on the Ground in the Middle East

DJ

Lezen

30 mrt 2026, 22:13 UTC

Acquisities, Fusies, Overnames

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

DJ

Lezen

30 mrt 2026, 21:00 UTC

Winsten

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

DJ

Lezen

30 mrt 2026, 20:15 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

DJ

Lezen

30 mrt 2026, 23:40 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

30 mrt 2026, 23:40 UTC

Marktinformatie

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

DJ

Lezen

30 mrt 2026, 23:36 UTC

Marktinformatie

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

DJ

Lezen

30 mrt 2026, 23:12 UTC

Marktinformatie

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

DJ

Lezen

30 mrt 2026, 22:49 UTC

Marktinformatie

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

DJ

Lezen

30 mrt 2026, 22:44 UTC

Marktinformatie

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

DJ

Lezen

30 mrt 2026, 22:43 UTC

Marktinformatie

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

DJ

Lezen

30 mrt 2026, 22:42 UTC

Marktinformatie

South32 Should Go for Growth, Says New Bull -- Market Talk

DJ

Lezen

30 mrt 2026, 22:18 UTC

Marktinformatie

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

DJ

Lezen

30 mrt 2026, 22:05 UTC

Marktinformatie

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

DJ

Lezen

30 mrt 2026, 21:58 UTC

Acquisities, Fusies, Overnames

Sun Life Financial Agrees to Buy Bell Partners for $350M

DJ

Lezen

30 mrt 2026, 21:39 UTC

Acquisities, Fusies, Overnames

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

DJ

Lezen

30 mrt 2026, 21:38 UTC

Acquisities, Fusies, Overnames

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

DJ

Lezen

30 mrt 2026, 21:36 UTC

Acquisities, Fusies, Overnames

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

DJ

Lezen

30 mrt 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

DJ

Lezen

30 mrt 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

DJ

Lezen

30 mrt 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

DJ

Lezen

30 mrt 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

DJ

Lezen

30 mrt 2026, 21:33 UTC

Acquisities, Fusies, Overnames

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

DJ

Lezen

30 mrt 2026, 21:25 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

30 mrt 2026, 21:25 UTC

Marktinformatie

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

DJ

Lezen

30 mrt 2026, 21:03 UTC

Acquisities, Fusies, Overnames

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

DJ

Lezen

30 mrt 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

30 mrt 2026, 20:09 UTC

Winsten

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

DJ

Lezen

30 mrt 2026, 20:00 UTC

Belangrijke Nieuwsgebeurtenissen

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

DJ

Lezen

Peer Vergelijking

Prijswijziging

Cellectar Biosciences Inc Prognose

Koersdoel

By TipRanks

344.44% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 12Ā USDĀ  344.44%

Hoogste 14Ā USD

Laagste 10Ā USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Cellectar Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Cellectar Biosciences Inc - Dist in de afgelopen 3 maanden.

Financieel

$

Andere aandelen uit de sector

MDT

Medtronic PLC

86.56

ā†‘ +0.83%

A

Agilent Technologies Inc

113.95

ā†‘ +1.74%

VEEV

Veeva Systems Inc

175.31

ā†‘ +0.07%

HQY

HealthEquity Inc

83.18

ā†‘ +1.87%

CSBR

Champions Oncology Inc

5.69

ā†‘ +2.34%
help-icon Live chat